StoneX Group’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRY
StoneX Group's SPRY Position: Q3 2026 in Review
StoneX Group opened a new position in ARS Pharmaceuticals (SPRY) in Q3 2026: 10,155 shares worth $60.9K. The stake represents ﹤0.01% of the portfolio and ranks #1573 among its holdings. This is a return to the name: StoneX Group previously reported a position in SPRY as recently as Q3 2023.
StoneX Group first reported a position in SPRY in Q3 2023 and has held it in 2 quarters since. 189 funds tracked by Wall St. Rank hold SPRY as of Q3 2026.
- StoneX Group held 10,155 shares of ARS Pharmaceuticals worth $60.9K as of Q3 2026.
- ARS Pharmaceuticals was a new StoneX Group position in Q3 2026.
- ARS Pharmaceuticals made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1573 holding.
- StoneX Group first reported a position in ARS Pharmaceuticals in Q3 2023 and has held it in 2 quarters since.
- 189 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q3 2026.
Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.